Abstract
OBJECTIVE: Food is considered a reinforcing agent, like a variety of substances such as alcohol and other drugs of abuse that produce pleasure. Psychopathological traits related to food intake are demonstrated in eating disorders as in obesity with different genetic aspects for these diseases. Recently, the prevalence of TaqA1 allele has been associated to alcohol, drug abuse and carbohydrate preference. For this reason, the aim of this study was to evaluate if the presence of A1 allele, in eating disorders and obesity, is associated with some particular psycho-pathological characteristics. METHODS: We studied the presence of TaqA1 in Italian subjects affected by obesity (n=71), anorexia (n=28), bulimia (n=20) and in control group (n=54). The Eating Disorders Inventory (EDI test) was used to evaluate the psychological profiles. Patients without alcohol and drugs abuse were selected (>125 ml/day). RESULTS: The A1+ allele, both in A1/A1 and A1/A2 genotypes, was not differently distributed among disease groups; on the contrary two EDI subscales (Drive for thinness and Ineffectiveness) resulted associated with A1+ allele without effect of the eating disease or obesity. CONCLUSION: These results confirm that the presence of A1+ allele is not simply related to body weight but the A1+ allele might be a marker of a genetic psychological condition in people with high risk to develop pathological eating behaviour.
Similar content being viewed by others
References
Hinney A., Remschmidt H., Hebebrand J.: Candidate gene polymorphisms in eating disorders. Eur. J. Pharmacol., 410, 147–159, 2000.
Klump K.L., Kaye W.H., Strober M.: The evolving genetic foundation of eating disorders. Psychiatr. Clin. North Am., 24, 215–225, 2001.
Bergen A.W., Yeager M., Welch R., Ganjei J.K., Deep-Soboslay A., Haque K., van der Bree M.B.M., Goldman D., Berrettini W.H., Kaye W.H.: Price Foundation Collaborative Group: Candidate gene analysis of the Price Foundation Anorexia nervosa affected relative pair dataset. Current drug targets. CNS neurological disorders, 2, 41–51, 2003.
Snyder E.E., Walts B., Pérusse L., Chagnon Y.C., Weisnagel S.J., Rankinen T., Bouchard C.: The human Obesity Gene Map: the 2003 update. Obes. Res., 12, 369–439, 2004.
Gorwood P., Kipman A., Foulon C.: The human genetics of anorexia nervosa. Eur. J. Pharmacol., 480, 163–170, 2003.
Kaye W.H., Devlin B., Barbarich N., Bulik C.M., Thornton L., Bacanu S.A., Fichter M.M., Halmi K.A., Kaplan A.S., Strober M., Woodside D.B., Bergen A.W., Crow S., Mitchell J., Rotondo A., Mauri M., Cassano G., Keel P., Plotnicov K., Pollice C., Klump K.L., Lilenfeld L.R., Ganjei J.K., Quadflieg N., Berettini W.H.: Genetic analysis of bulimia nervosa: methods and sample description. Int. J. Eat. Disord., 35, 556–570, 2004.
Kowalski T.J.: The future of genetic research on appetite behaviour. Appetite, 42, 11–14, 2004.
Bruins-Slot L., Gorwood P., Bouvard M., Blot P., Ades J., Feingold J., Schwartz J.C., Mouren-Simeoni M.C.: Lack of association between anorexia nervosa and D3 dopamine receptor gene. Biol. Psychiatry, 43, 76–78, 1998.
Hinney A., Schneider J., Ziegler A., Lehmkuhl G., Poustka F., Schmidt M.H., Mayer H., Siegfried W., Remschmidt H., Hebebrand J.: No evidence for involvement of polymorphisms of the dopamine D4 receptor gene in anorexia nervosa, underweight, and obesity. Am. J. Med. Genet., 88, 594–597, 1999.
Shinohara M., Mizushima H., Hirano M., Shioe K., Nakazawa M., Yoshimitsu H., Yutaka O., Shigenobu K.: Eating disorders with binge-eating behaviour are associated with the s allele of the 3′-UTR VNTR polymorphism of the dopamine transporter gene. J. Psychiatr. Neurosci., 29, 134–137, 2004.
Bergen A.W., Yeager M., Welch R.A., Haque K., Ganjei J.K., van der Bree M.B., Mazzanti C., Nardi I., Fichter M.M., Halmi K.A., Kaplan A.S., Strober M., Treasure J., Woodside D.B., Bulik C.M., Bacanu S.A., Devlin B., Berrettini W.H., Goldman D., Kaye W.H.: Association of multiple DRD2 polymorphisms with anorexia nervosa. Neuropsychopharmacology, 30, 1703–1710, 2005.
Thompson J., Thomas N., Singleton A., Piggott M., Lloyd S., Perry E.K., Morris C.M., Perry R.H., Ferrier I.N., Court J.A.: D2 dopamine receptor gene (DRD2) Taq1 A polymorphism: reduced dopamine D2 receptor binding in the human striatum associated with the A1 allele. Pharmacogenetics, 7, 479–484, 1997.
Thomas G.N., Critchley J.H., Tomlinson B., Cockram C.S., Chan J.C.N.: Relationships between the TaqI polymorphism of the dopamine D2 receptor and blood pressure in hyperglycaemic and normoglycaemic Chinese subjects. Clin. Endocrinol., 55, 605–611, 2001.
Comings D.E., Gade R., MacMurray J.P., Muhleman D., Peters W.R.: Genetic variants of the human obesity (OB) gene: association with body mass index in young women, psychiatric symptoms and interaction with the dopamine D2 receptor (DRD2) gene. Mol. Psychiatry, 1, 325–335, 1996.
Comings D.E., Flanagan S.D., Dietz G., Muhleman D., Knell E., Gysin R.: The dopamine D2 receptor (DRD2) as a major gene in obesity and height. Biochemical Medicine and Metabolic Biology, 50, 176–185, 1993.
Noble E.P., Noble R.E., Ritchie T., Syndulko K., Bohlman M.C., Noble L.A., Zhang Y., Sparkes R.S., Grandy D.K.: D2 dopamine receptor gene and obesity. Int. J. Eat. Disord., 15, 205–217, 1994.
Blum K., Sheridan P.J., Wood R.C., Braverman E.R., Chen T.J., Cull J.C., Comings D.E.: The D2 dopamine receptor gene as a determinant of reward deficiency syndrome. J. Roy. Soc. Med., 89, 396–400, 1996.
Noble E.P.: D2 dopamine receptor gene in psychiatric and neurologic disorders and its phenotypes. Am. J. Med. Gen., 116B, 103–125, 2003.
Conner B.T., Noble EP., Berman S.M., Ozkaragoz T., Ritchie T., Antolin T., Sheen C.: DRD2 genotypes and substance use in adolescent children of alcoholics. Drug Alcohol Dependence, 79, 379–387, 2005.
Neville M.J., Johnstone E.C., Walton R.T.: Identification and characterization of ANKK1: a novel kinase gene closely linked to DRD2 on chromosome band 11q23.1. Hum. Mutat., 23, 540–545, 2004.
Garner D.M., Olmstead M.P., Polivy J.: Development and validation of a multidimensional eating disorders inventory for anorexia-nervosa and bulimia. Int. J. Eat. Disord., 2, 15–34, 1983.
Rizzardi M., Trombini E., Trombini G., Gadner D.M.: EDI-2 adattamento italiano. Firenze, O.S., 1995.
Hinney A., Schneider J., Ziegler A., Lehmkuhl G., Poustka F., Schmidt M.H., Mayer H., Siegfried W., Remschmidt H., Hebebrand J.: No evidence for involvement of polymorphisms of the dopamine D4 receptor gene in anorexia nervosa, underweight and obesity. Am. J. Med. Genetics, 88, 594–597, 1999.
Jenkinson C.P., Hanson R., Cray K., Wiedrich C., Knowler W.C., Bogardus C., Baier L.: Association of dopamine D2 receptor polymorphisms Ser311Cys and Taq1A with obesity or type 2 diabetes mellitus in Pima Indians. Int. J. Obes., 24, 1233–1238, 2000.
Southon A., Walder K., Sanigorski A.M., Zimmet P., Nicholson G.C., Kotowicz M.A., Collier G.: The Taq1A and Ser311Cys polymorphisms in the dopamine D2 receptor gene and obesity. Diab. Nutr. Metab., 16, 72–76, 2003.
Young R.McD., Lawford B.R., Feeney G.F.X., Ritchie T., Noble EP.: Alcohol-related expectancies are associated with the D2 dopamine receptor and GABAA receptor β3 subunit genes. Psychiatry Res., 127, 171–183, 2004.
Connor J.P., Young R.McD., Lawford B.R., Ritchie T.L., Noble E.P.: D2 dopamine receptor polymorphism is associated with severity of alcohol dependence. Eur. Psychiatry, 17, 17–23, 2002.
Van der Stelt M., Di Marzo V.: The endocannabinoid system in the basal ganglia and in the mesolimbic reward system: implications for neurological and psychiatric disorders. Eur. J. Pharmacol., 480, 133–150, 2003.
Pohjalainen T., Rinne J.O., Naguen K., Lehikoinen P., Antila K., Syvalahti E.K., Hietela J.: The A1 allele of the human dopamine D2 receptor gene predicts low D2 receptor availability in healthy volunteers. Mol. Psychiatry, 3, 256–360, 1998.
Volkow N.D., Fowler J.S.: Addiction, a disease of compulsion and drive: involvement of the orbitofrontal cortex. Cerebral Cortex, 10, 318–325, 2000.
Epstein L.H., Wright S.M., Paluch R.A., Leddy J.J., Hawk L.W. Jr,, Jaroni J.L., Saad F.G., Crystal-Mansour S., Shields P.G., Lerman C.: Relation between food reinforcement and dopamine genotypes and its effect on food intake in smokers. Am. J. Clin. Nutr., 80, 82–88, 2004.
Blum K., Braverman E.R., Wood R.C., Gill J., Li C., Chen T.J., Taub M., Montgomery A.R., Sheridan P.J., Cull J.C.: Increased prevalence of the TaqI A1 allele of dopamine receptor gene (DRD2) in obesity with comorbid substance use disorder: a preliminary report. Pharmacogenetics, 6, 297–305, 1996.
Hinney A., Friedel S., Remschidt H., Hebebrand J.: Genetic risk factors in eating disorders. Am. J. Pharmacogenomics, 4, 209–223, 2004.
Kaye W.H., Bulik C.M., Thornton L., Barbarich N., Masters K.: Comorbidity of anxiety disorders with anorexia and bulimia nervosa. Am. J. Psychiatry, 161, 2215–2221, 2004.
Milos G., Spindler A., Schnyder U.: Psychiatric comorbidity and Eating Disorder Inventory (EDI) profiles in eating disorder patients. Can. J. Psychiatry, 49, 179–184, 2004.
Devlin B., Bacanu S.A., Klump K.I., Bulik C.M., Fichter M.M., Halmi K.A., Kaplan A.S., Strober M., Treasure J., Woodside D.B., Kaye W.H.: Linkage analysis of anorexia nervosa incorporating behavioral covariates. Hum. Mol. Genetics, 11, 689–696, 2002.
Bulik C.M., Klump K.L., Thornton L., Kaplan A.S., Devlin B., Fichter M.M., Halmi K.A., Strober M., Woodside D.B., Crow S., Mitchell J., Rotondo A., Mauri M., Cassano G., Keel P., Berettini W.H., Kaye W.H.: Alcohol use disorder comorbidity in eating disorders: a multicenter study. J. Clin. Psychiatry, 65, 1000–1006, 2004.
Limbert C.: The eating disorders inventory: a test of the factor structure and internal consistency in a nonclinical sample. Health Care for Women International, 25, 165–178, 2004.
Fairburn C.G., Welch S.L., Doll H.A., Davies B.A., O’Connor M.E.: Risk factors for bulimia nervosa. A community-based case-control study. Arch. Gen. Psychiatry, 54, 509–517, 1997.
Fairburn C.G., Cooper Z., Doll H.A., Welch S.L.: Risk factors for anorexia nervosa: three integrated casecontrol comparisons. Arch. Gen. Psychiatry, 56, 468–476, 1999.
Lawford B.R., Young R.McD., Noble E.P., Sargent J., Rowell J., Shadforth S., Zhang X., Ritchie T.: The D2 dopamine receptor A1 allele and opioid dependence: association with heroin use and response to methadone treatment. Am. J. Med. Genetics, (Neuropsychiatric Genetics), 96, 592–598, 2000.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Nisoli, E., Brunani, A., Borgomainerio, E. et al. D2 dopamine receptor (DRD2) gene Taq1A polymorphism and the eatingrelated psychological traits in eating disorders (anorexia nervosa and bulimia) and obesity. Eat Weight Disord 12, 91–96 (2007). https://doi.org/10.1007/BF03327583
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03327583